Cargando…
Inhibition of microRNA let‐7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer
MicroRNA let‐7b is a potent tumor suppressor and targets crucial oncogenes. Previous studies have shown that let‐7b expression is suppressed in ovarian cancer; however, the regulatory mechanisms of let‐7b in ovarian cancer are still not well defined. The cellular role and targets of let‐7b in ovaria...
Autores principales: | Kuang, Yan, Xu, Hong, Lu, Fangfang, Meng, Jiahua, Yi, Yeye, Yang, Huilan, Hou, Hairui, Wei, Hao, Su, Shanheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780014/ https://www.ncbi.nlm.nih.gov/pubmed/33091189 http://dx.doi.org/10.1111/cas.14708 |
Ejemplares similares
-
Distinct and separable roles for EZH2 in neurogenic astroglia
por: Hwang, William W, et al.
Publicado: (2014) -
Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo
por: Kuang, Yan, et al.
Publicado: (2017) -
CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity
por: Huo, Xiao, et al.
Publicado: (2020) -
Neurotrophic factors combined with stem cells in the treatment of sciatic nerve injury in rats: a meta-analysis
por: Liu, Kuang-Pin, et al.
Publicado: (2022) -
The KDM2B- Let-7b -EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy
por: Karoopongse, Ekapun, et al.
Publicado: (2014)